Solventum Corporation
SOLV
$72.30
$1.161.63%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.24% | -0.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.24% | -0.34% | |||
| Cost of Revenue | 0.96% | 2.18% | |||
| Gross Profit | -1.23% | -2.32% | |||
| SG&A Expenses | 3.48% | 6.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.76% | 3.70% | |||
| Operating Income | -19.19% | -27.21% | |||
| Income Before Tax | 171.43% | -91.62% | |||
| Income Tax Expenses | -482.35% | -137.78% | |||
| Earnings from Continuing Operations | 341.94% | -74.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 341.94% | -74.59% | |||
| EBIT | -19.19% | -27.21% | |||
| EBITDA | -16.95% | -14.07% | |||
| EPS Basic | 341.11% | -74.59% | |||
| Normalized Basic EPS | -26.43% | -54.49% | |||
| EPS Diluted | 336.24% | -74.46% | |||
| Normalized Diluted EPS | -26.45% | -54.65% | |||
| Average Basic Shares Outstanding | 0.17% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.17% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||